1. Home
  2. RGC

as 07-26-2024 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
-
.
-
-
%

Stocks

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

Founded: 2014 Country:
Hong Kong
Hong Kong
Employees: N/A City: N/A
Market Cap: 65.1M IPO Year: 2021
Target Price: N/A AVG Volume (30 days): 263.9K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.45 EPS Growth: N/A
52 Week Low/High: $3.03 - $32.44 Next Earning Date: 06-20-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

RGC Daily Stock ML Predictions

Share on Social Networks: